| Date | Title | Description | Source |
| 26.06.2023 | Pharvaris obtains $70 million in a private placement round |
Pharvaris (Nasdaq: PHVS) has entered into a subscription agreement relating to the offer and sale ... | startuptic... |
| 04.06.2021 | StartUPDATES: New developments for healthcare startups | Stellar Health is pleased to announce the appointment of JoRel Nye, former Senior Vice President of ... | medcitynew... |
| 04.06.2021 | venBio Closes Venture Capital Fund Focused on Life Sciences,... | venBio, a Palo Alto, CA and San Francisco, CA-based closed its fourth life sciences venture capital ... | finsmes.co... |
| 03.06.2021 | Salesforce wants to battle Microsoft. But will it get Slack ... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 19.11.2020 | Pharvaris Announces $80 Million Series C Financing |
Hereditary angioedema (HAE) is a rare and potentially life-threatening genetic condition with symp... | startuptic... |
| 19.11.2020 | Pharvaris Announces $80 Million Series C Financing | Hereditary angioedema (HAE) is a rare and potentially life-threatening genetic condition with sympto... | startuptic... |
| 06.04.2020 | venBio closes third fund for biopharma startup investment, v... | “We remain committed to our founding strategy at venBio, namely to turn great science into impactful... | medcitynew... |
| 03.04.2020 | venBio Closes Life Sciences Venture Capital Fund, at $394M | venBio Partners, a San Francisco, and Palo Alto, CA-based life sciences venture capital firm, closed... | finsmes.co... |
| 25.06.2018 | Akero Therapeutics Closes $65 Million Series A | Akero Therapeutics, Inc., a biotechnology company focused on transforming the treatment of non-alcoh... | citybizlis... |
| 04.01.2018 | Neurogastrx Raises $45M Series A | Neurogastrx, Inc., a private biopharmaceutical company focused on discovering and developing therapi... | citybizlis... |
| 18.07.2017 | Rock Springs Capital Joins $50M Series C for Menlo Therapeut... | Menlo Therapeutics Inc. announced today that the company has raised $50M to advance development of s... | citybizlis... |
| 18.07.2017 | F-Prime Capital Joins $50M Series C for Menlo Therapeutics | Menlo Therapeutics Inc. announced today that the company has raised $50M to advance development of s... | citybizlis... |
| 05.05.2017 | A $2B oncology deal goes bust at the hands of an activist in... | But behind the scenes, venBio wasn’t having any of it. The group moved quickly to get a 30-day hold ... | medcitynew... |
| 03.12.2016 | Impel NeuroPharma raises $36M for drug delivery platform tha... | Impel NeuroPharma co-founder and CEO John Hoekman. (Impel NeuroPharma Photo)
Impel NeuroPharma, a S... | geekwire.c... |
| 06.05.2016 | venBio Partners Closes Second Life Sciences Venture Capital ... | venBio Partners LLC, a global life sciences investment firm, closed its second venture capital fund,... | finsmes.co... |
| 06.05.2016 |
Amgen Backs New $315M Life Sciences Fund
| Thousand Oaks-based Amgen has helped to back a new, life sciences fund, managed by San Francisco-bas... | socaltech.... |
| 22.03.2016 | VenBio Raises $288M for Second Venture Capital Fund | VenBio, LLC, a bi-coastal healthcare venture capital firm, raised $288m for its second fund.
Accord... | finsmes.co... |
| 30.12.2015 | Solstice Biologics raises $4M – but where did CEO Lou Tartag... | But Lou Tartaglia, a former partner at Boston-based Third Rock Ventures with a long history in succe... | medcitynew... |
| 12.08.2015 | Daily funding roundup - August 12, 2015 | PokitDoc closed $34M; Infogain secured $63M; Soothe raised $10.6M
If there's a service that I often... | vator.tv/n... |
| 12.08.2015 | Checkmate nets $20M to develop drug that boosts checkpoint i... | Checkmate Pharmaceuticals operates on the idea that checkpoint inhibitor therapies would be much mor... | medcitynew... |
| 27.07.2015 | Daily funding roundup - July 27, 2015 | Palantir received $450M; DraftKings added $300M; Secret Escapes bagged $60M
Buyatab Online Inc., a ... | vator.tv/n... |
| 04.10.2012 | Aragon Pharmaceuticals Inks $50M Series D |
SAN DIEGO, CA, Aragon raised $50 million in a Series D financing to advance the company's pipeline... | vcnewsdail... |
| 04.10.2012 | Aragon Pharmaceuticals Raises $50M in Series D Financing | Aragon Pharmaceuticals Inc., a San Diego, California-based developer of 2nd generation anti-hormonal... | finsmes.co... |
| 26.01.2010 | A new model for life-sciences venture firms? MedCity Morning... | Promoted
Clinical Care Capacity Planning
Learn how to manage clinical care capacity more efficient... | medcitynew... |
| - | venBio closes third fund for biopharma startup investment, v... | A venture capital firm focused on life sciences has closed a fund worth nearly $400 million that it ... | medcitynew... |
| - | Checkmate nets $20M to develop drug that boosts checkpoint i... | The name of the company’s pretty pithy: Checkmate Pharmaceuticals, so-called because its drug in dev... | medcitynew... |
| - | A $2B oncology deal goes bust at the hands of an activist in... | Activist investor venBio had a good Friday. Seattle Genetics and Immunomedics did not. The two latte... | medcitynew... |
| - | StartUPDATES: New developments for healthcare startups | Stellar Health is pleased to announce the appointment of JoRel Nye, former Senior Vice President of ... | medcitynew... |
| - | Solstice Biologics raises $4M – but where did CEO Lou Tartag... | Looks like Solstice Biologics, the tumultuous San Diego biotech that’s developing some promising RNA... | medcitynew... |
| - | A new model for life-sciences venture firms? MedCity Morning... | Highlights of the important and the interesting from the world of health care:
A new model for life... | medcitynew... |